Sernova Biotherapeutics Inc (SVA.TO)
Develops a pouch that implants cells in the body to treat diseases like diabetes and hemophilia
0.12-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-39.5%
The outlook
SVA.TO is trading near its 52-week lows, well below both its 50- and 200-day moving averages, reflecting weak near-term momentum. Analyst coverage shows a notably bullish average price target about 291% above the current price, though the overall StockGlow score leans bearish. The stock sits at the lower end of its yearly range, suggesting significant distance from recent highs.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +291% vs current price
Market cap
$43.4M
52-wk high
0.21
52-wk low
0.11
50-day avg
0.14
200-day avg
0.15
Trailing P/E
—